Phase I-II study of bendamustine in patients with acute leukemia and high risk myelodysplastic syndrome.
Phase I-II study of bendamustine in patients with acute leukemia and high risk myelodysplastic syndrome. Clin Lymphoma Myeloma Leuk. 2012 Jun; 12(3):197-200.